Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic Leukemia
JCO Oncol Pract
.
2020 Sep;16(9):613-614.
doi: 10.1200/OP.20.00022.
Epub 2020 Jun 30.
Authors
Nirav N Shah
1
,
James H Jerkins
1
,
Bryon D Johnson
1
,
Parameswaran Hari
1
Affiliation
1
Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI.
PMID:
32603254
DOI:
10.1200/OP.20.00022
No abstract available
MeSH terms
Humans
Immunotherapy, Adoptive
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Purines
Quinazolinones
Tumor Lysis Syndrome* / etiology
Substances
Purines
Quinazolinones